Close
ACHEMA MIDDLE EAST 2026
DDF Summit 2025

Tag: America

Browse our exclusive articles!

GSK to Invest $30B in Drug Manufacturing and R&D in the US

GSK plc has unveiled a plan to invest $30 billion into research, development and supply chain infrastructure across the United States. The announcement includes...

FDA Approves Sanofi’s Wayrilz for Immune Thrombocytopenia

The US FDA approves Sanofi’s Wayrilz (rilzabrutinib) for use in adult patients with chronic or persistent immune thrombocytopenia (ITP) who did not respond adequately...

Roche’s Genentech Launches New Manufacturing Facility in USA

Genentech, part of the Roche Group, has broken ground on its latest US manufacturing facility in Holly Springs, North Carolina. The development represents the...

AbbVie to Acquire Gilgamesh Pharmaceuticals’ Bretisilocin, a Novel, Investigational Therapy for Major Depressive Disorder, Expanding Psychiatry Pipeline

NORTH CHICAGO, Ill. and NEW YORK, Aug. 25, 2025 -- AbbVie and Gilgamesh Pharmaceuticals Inc. ("Gilgamesh") announced a definitive agreement under which AbbVie will...

Pharmaceutical Tariff Agreed at 15% Under US-EU Trade Deal

Pharmaceutical tariffs between the European Union and the United States will now be limited at 15% under the terms of the latest trade agreement,...

Popular

Building the Right Team and Resource Model to Support Quality System and Validation Activities

Since life science quality and validation projects can vary...

Merck and Blackstone Enter R&D Funding Agreement for sac-TMT

Merck, recognized as MSD outside the U.S. and Canada,...

FDA Approves J&J’s DARZALEX FASPRO for HR-SMM in Adults

Johnson & Johnson said the U.S. Food and Drug...

FDA Approves UCB’s KYGEVVI for Thymidine Kinase 2 Deficiency

UCB, a leading global biopharmaceutical company, has announced that...

Subscribe

spot_imgspot_img